S-1 plus Oxaliplatin combination chemotherapy in a stop-and-go fashion for metastatic colorectal cancer
Phase 2
- Conditions
- Metastatic colorectal cancer
- Registration Number
- JPRN-UMIN000004086
- Lead Sponsor
- Yodogawa Christian Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Medical history of severe anaphylaxis or allergia to any drug 2) Pregnant or lactating woman at any time during study. Men of the fertility hope. 3) Serious infection 4) Severe complications 5) Severe cardiac disease 6) Neuropathy 7) Severe diarrhea 8) Massive pleural or abdominal effusion 9) High grade stenosis at the primary tumor 10) Presence of peritoneal dissemination or peritoneal tuberosity assessed by image test 11) Brain metastasis 12) Double cancer 13) Prior adjuvant chemotherapy with oxaliplatin containing regimen 14) Systemic administration of corticosteroids 15) Patients who are judged inappropriate for the entry into the study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method